Suppr超能文献

某中心儿童囊性纤维化急性肺部加重门诊管理指南

One Center's Guide to Outpatient Management of Pediatric Cystic Fibrosis Acute Pulmonary Exacerbation.

作者信息

Muirhead Corinne A, Sanford Jillian N, McCullar Benjamin G, Nolt Dawn, MacDonald Kelvin D

机构信息

Department of Pharmacy, Oregon Health and Science University, Doernbecher Children's Hospital, Portland, OR, USA.

Department of Pediatrics, Oregon Health and Science University, Doernbecher Children's Hospital, Portland, OR, USA.

出版信息

Clin Med Insights Pediatr. 2016 Jul 12;10:57-65. doi: 10.4137/CMPed.S38336. eCollection 2016.

Abstract

Cystic fibrosis (CF) is a chronic disorder characterized by acute pulmonary exacerbations that comprise increased cough, chest congestion, increased mucus production, shortness of breath, weight loss, and fatigue. Typically, severe episodes are treated in the inpatient setting and include intravenous antimicrobials, airway clearance therapy, and nutritional support. Children with less-severe findings can often be managed as outpatients with oral antimicrobials and increased airway clearance therapy at home without visiting the specialty CF center to begin treatment. Selection of specific antimicrobial agents is dependent on pathogens found in surveillance culture, activity of an agent in patients with CF, and the unique physiology of these patients. In this pediatric review, we present our practice for defining acute pulmonary exacerbation, deciding treatment location, initiating treatment either in-person or remotely, determining the frequency of airway clearance, selecting antimicrobial therapy, recommending timing for follow-up visit, and recognizing and managing treatment failures.

摘要

囊性纤维化(CF)是一种慢性疾病,其特征为急性肺部加重,表现为咳嗽加剧、胸部充血、黏液分泌增加、呼吸急促、体重减轻和疲劳。通常,严重发作需在住院环境中治疗,包括静脉使用抗菌药物、气道清除治疗和营养支持。症状较轻的儿童通常可作为门诊患者,在家中使用口服抗菌药物并增加气道清除治疗,无需前往专科CF中心开始治疗。特定抗菌药物的选择取决于监测培养中发现的病原体、该药物在CF患者中的活性以及这些患者的独特生理状况。在这篇儿科综述中,我们介绍了我们在定义急性肺部加重、决定治疗地点、亲自或远程启动治疗、确定气道清除频率、选择抗菌治疗、推荐随访时间以及识别和处理治疗失败方面的做法。

相似文献

1
One Center's Guide to Outpatient Management of Pediatric Cystic Fibrosis Acute Pulmonary Exacerbation.
Clin Med Insights Pediatr. 2016 Jul 12;10:57-65. doi: 10.4137/CMPed.S38336. eCollection 2016.
2
[Chinese experts consensus statement: diagnosis and treatment of cystic fibrosis (2023)].
Zhonghua Jie He He Hu Xi Za Zhi. 2023 Apr 12;46(4):352-372. doi: 10.3760/cma.j.cn112147-20221214-00971.
3
Oral antimicrobial use in outpatient cystic fibrosis pulmonary exacerbation management: a single-center experience.
Clin Respir J. 2012 Jan;6(1):56-64. doi: 10.1111/j.1752-699X.2011.00246.x. Epub 2011 Aug 9.
4
The effects of the addition of a new airway clearance device to chest physiotherapy in children with cystic fibrosis pulmonary exacerbations.
J Mother Child. 2021 Jan 26;24(3):16-24. doi: 10.34763/jmotherandchild.20202403.2013.d-20-00008.
5
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis.
Cochrane Database Syst Rev. 2019 Jan 7;1(1):CD009841. doi: 10.1002/14651858.CD009841.pub3.
6
Airway clearance techniques compared to no airway clearance techniques for cystic fibrosis.
Cochrane Database Syst Rev. 2023 Apr 12;4(4):CD001401. doi: 10.1002/14651858.CD001401.pub4.
7
Pulmonary exacerbations in cystic fibrosis: young children with characteristic signs and symptoms.
Pediatr Pulmonol. 2013 Jul;48(7):649-57. doi: 10.1002/ppul.22658. Epub 2012 Sep 4.
9
Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.
Cochrane Database Syst Rev. 2015 Jun 17(6):CD003147. doi: 10.1002/14651858.CD003147.pub4.

引用本文的文献

1
Telemedicine in Pediatric Infectious Diseases.
Children (Basel). 2021 Mar 28;8(4):260. doi: 10.3390/children8040260.

本文引用的文献

1
Clinical Practice Guidelines From the Cystic Fibrosis Foundation for Preschoolers With Cystic Fibrosis.
Pediatrics. 2016 Apr;137(4). doi: 10.1542/peds.2015-1784. Epub 2016 Mar 23.
2
3
An evaluation strategy for potential QTc prolongation with chronic azithromycin therapy in cystic fibrosis.
J Cyst Fibros. 2016 Mar;15(2):192-5. doi: 10.1016/j.jcf.2015.11.012. Epub 2015 Dec 12.
4
Burkholderia cepacia complex: clinical course in cystic fibrosis patients.
BMC Pulm Med. 2015 Dec 8;15:158. doi: 10.1186/s12890-015-0148-2.
5
Pulmonary Exacerbations in Children with Cystic Fibrosis.
Ann Am Thorac Soc. 2015 Nov;12 Suppl 2:S200-6. doi: 10.1513/AnnalsATS.201502-098AW.
6
Fluoroquinolone-associated tendon-rupture: a summary of reports in the Food and Drug Administration's adverse event reporting system.
Expert Opin Drug Saf. 2015;14(11):1653-60. doi: 10.1517/14740338.2015.1085968. Epub 2015 Sep 22.
8
Prolongation of antibiotic treatment for cystic fibrosis pulmonary exacerbations.
J Cyst Fibros. 2015 Nov;14(6):770-6. doi: 10.1016/j.jcf.2015.07.010. Epub 2015 Aug 9.
9
Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.
Pediatr Pulmonol. 2015 Aug;50(8):763-70. doi: 10.1002/ppul.23217. Epub 2015 Jun 9.
10
Emerging bacterial pathogens and changing concepts of bacterial pathogenesis in cystic fibrosis.
J Cyst Fibros. 2015 May;14(3):293-304. doi: 10.1016/j.jcf.2015.03.012. Epub 2015 Apr 14.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验